Klp Kapitalforvaltning As Recursion Pharmaceuticals, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 51,200 shares of RXRX stock, worth $392,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,200Holding current value
$392,192% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
308Shares Held
252MCall Options Held
1.35MPut Options Held
2.32M-
Vanguard Group Inc Valley Forge, PA34MShares$261 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$248 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$190 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$133 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$118 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.38B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...